Target intelligence / Profile preview

Fibroblast growth factor 2 (FGF2) (FGF2)

Target
FGF2
Molecular classification
Growth factor, Heparin-binding protein
01

Overview

Fibroblast growth factor 2 (FGF2), also known as basic fibroblast growth factor (bFGF), is a pleiotropic growth factor and a member of the fibroblast growth factor family. It plays a critical role in physiological processes such as cell proliferation, differentiation, survival, migration, tissue repair, and angiogenesis. FGF2 exerts its biological effects by binding to and activating cell-surface fibroblast growth factor receptors (FGFR1-4) in a process facilitated by heparan sulfate proteoglycans.

In pathological contexts, dysregulated FGF2 signaling is heavily implicated in tumor growth, metastasis, and resistance to anti-VEGF therapies, as well as in neovascular age-related macular degeneration (nAMD) and skeletal disorders like achondroplasia. Consequently, FGF2 is a key therapeutic target. Therapeutic strategies include neutralizing FGF2 with RNA aptamers (such as umedaptanib pegol) or monoclonal antibodies, and sequestering it using soluble decoy receptors (like GSK3052230). Conversely, recombinant human FGF2 (trafermin) is utilized as an agonist to promote wound healing and tissue regeneration.

Other names
Basic fibroblast growth factorbFGFHeparin-binding growth factor 2HBGF-2FGF-2Prostatropin
02

Mechanism of action

Ligand neutralization, receptor activation, and ligand sequestration

03

Biological functions

Cell proliferationAngiogenesisCell differentiationCell survivalCell migrationWound healing
04

Disease associations

CancerNeovascular age-related macular degenerationAchondroplasiaCardiovascular diseaseFibrosis
05

Safety considerations

HypotensionIncreased mortality at high systemic dosesRetinal fluid changesOff-target FGFR activationCardiovascular toxicity
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

FGF2 serum levelFGF2 expression levelFGFR1 expression levelSyndecan-1 (SDC1) expression level

Beyond the preview

Go deeper on Fibroblast growth factor 2 (FGF2) (FGF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroblast growth factor 2 (FGF2) (FGF2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call